Neck News and Research

RSS

Robotic surgery shows promise for local control of OSCC

In individuals with low-risk oropharyngeal squamous cell carcinoma, treatment with transoral robotic surgery alone can result in an excellent rate of local disease control for up to 3 years, report researchers.

19 Jul 2012

Pioneering technique that uses thermal imaging can help fight obesity

Scientists at The University of Nottingham believe they've found a way of fighting obesity — with a pioneering technique which uses thermal imaging. This heat-seeking technology is being used to trace our reserves of brown fat — the body's 'good fat' — which plays a key role in how quickly our body can burn calories as energy.

19 Jul 2012

HNCA post-treatment depression impairs life quality

Individuals undergoing treatment for head and neck cancer have a high incidence of depression, US researchers show.

18 Jul 2012

Computerized mobilization eases chronic neck pain

Computerized mobilization of the cervical spine appears to be a viable treatment option for patients with chronic neck pain, a proof-of-concept trial shows.

17 Jul 2012

Health law continues to be challenge for Romney campaign

GOP presidential hopeful Mitt Romney continues to confront issues about the similarities between the health reform he signed while Massachusetts governor and the 2010 federal health law. Meanwhile, The Associated Press reports about some of Romney's potential running mates and key issues in the campaign.

17 Jul 2012

BioControl Medical receives FDA approval to initiate second phase of CardioFit study for heart failure

BioControl Medical has announced U.S. Food and Drug Administration approval to begin the second phase of INOVATE-HF (INcrease Of VAgal TonE in Heart Failure), a global, multi-center, investigational device exemption (IDE) clinical study of the company's CardioFit system for heart failure.

12 Jul 2012

Victims of stray-bullet shootings are often children, females

Most people killed or wounded in stray-bullet shootings were unaware of events leading to the gunfire that caused their injuries, and nearly one-third of the victims were children and nearly half were female, according to a new nationwide study examining an often-overlooked form of gun violence.

11 Jul 2012

Study details development of first mouse model for Usher syndrome III

A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America.

11 Jul 2012

Obstructive sleep apnea worse in cold weather

Study findings based on observations from a sleep clinic in Brazil indicate that obstructive sleep apnea may worsen during the winter months.

10 Jul 2012

Sleep studies essential before bariatric surgery

Obstructive sleep apnea frequently goes undiagnosed in obese patients who undergo bariatric surgery, show findings from a US study.

10 Jul 2012

Osteopathic technique effective for people with work-related dysphonia

Vocal tract function can be substantially improved by the use of osteopathic myofascial techniques in people with work-related voice disorders, suggest study results.

10 Jul 2012

High ferritin warns of bone loss

Individuals with high levels of ferritin, an indicator of iron stores within the body, have accelerated bone loss at the proximal femur, Korean researchers report.

10 Jul 2012

Scientists identify novel strategy to target Taspase1 enzyme

Scientists at the University Medical Center of Johannes Gutenberg University Mainz in Germany identified a novel strategy to target the oncologically relevant protein-cleaving enzyme Taspase1.

10 Jul 2012

OREF study to explore how helmet design might protect sport-related head, neck and spine injuries

The Orthopaedic Research and Education Foundation (OREF) announced today it awarded a $200,000 Prospective Clinical Research Grant to researchers at the Cleveland Clinic Foundation to study ways to reduce the risk of spine, neck and head injuries to adults and youth playing football.

10 Jul 2012

Methylation provides signal of unique mix of leukocytes

When a person is sick, there is a tell-tale sign in their blood: a different mix of the various types of immune cells called leukocytes. A group of scientists at several institutions including Brown University has discovered a way to determine that mix from the DNA in archival or fresh blood samples, potentially providing a practical new technology not only for medical research but also for clinical diagnosis and treatment monitoring of ailments including some cancers.

10 Jul 2012

UTSMC could play key role in operating a proton therapy center for North Texas

UT Southwestern Medical Center, seeking to broaden an already robust array of radiation oncology treatments it offers to patients, potentially could play a key role in operating a state-of-the-art proton therapy center for North Texas being planned and funded by San Diego-based Advanced Particle Therapy (APT).

10 Jul 2012

Robot assists in complex uro surgery for pediatric patient

Pediatric specialists of Apollo Hospitals successfully completed a complex surgery on the bladder base of a 7 year old child from Africa with the assistance of a Robot. The child's urethra, the tube from the urinary bladder, was crushed in a road accident.

7 Jul 2012

Cystic fibrosis patient receives generous 'gift of life'

Meara Schmidt, 28, almost died a few weeks ago. Lying in her hospital bed at UCLA, the seriously ill cystic fibrosis patient felt herself slipping away and her life flashing by. But then the image of her husband appeared, and she knew she was not ready to go.

7 Jul 2012

Exercise-based treatment effective in treating persistent dizziness

A professor from the University of Southampton has called on doctors around the world to give patients with persistent dizziness a booklet of simple exercises, after new research has shown that it is a very cost effective treatment for common causes of the condition.

5 Jul 2012

Cancer Therapeutics announces validation and performance of CTx-294886 plus Avastin

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin (bevacizumab - Genentech/Roche) in a preclinical model of breast cancer.

5 Jul 2012